A new study reveals that older adults who received a high-dose flu vaccine experienced a significantly greater reduction in Alzheimer's risk (55%) compared to those receiving a standard dose (40%).
This finding is significant because it suggests a potential, non-invasive intervention for Alzheimer's prevention, building on previous research linking other vaccines to reduced dementia risk.
Future research is needed to understand the biological mechanisms behind the observed protective effect, especially the more pronounced benefit seen in women, which could lead to targeted prevention strategies.

Atlas AI
A recent study indicates that older adults receiving a high-dose influenza vaccine may experience a greater reduction in Alzheimer's disease risk compared to those receiving a standard dose. The research analyzed health data from approximately 200,000 participants aged 65 and older.
Participants who received the high-dose vaccine showed a 55% lower risk of Alzheimer's disease. This contrasts with a 40% reduction observed in those who received the standard vaccine dose.
Investigators noted that the protective effect of the high-dose flu vaccine was more pronounced in women than in men. The underlying biological mechanisms for this difference are not yet fully understood.
Previous research has also suggested a potential link between other vaccines, such as those for shingles, tetanus, diphtheria, and pneumonia, and a reduced risk of dementia.

